Indication
Condition
2 clinical trials
2 products
Product
LadarixinClinical trial
Influence of Food on the Oral Bioavailability of Ladarixin 200 mg Capsule in Healthy Volunteers of Both Sexes. A Single Dose (400 mg), Randomized, Open Label, Two-Way Crossover StudyStatus: Completed, Estimated PCD: 2020-12-09
Product
DF2755AClinical trial
An Ascending Dose Tolerability Study and Pharmacokinetic Assessment in Healthy Male and Female Volunteers After Single & Multiple Oral Administration of DF2755AStatus: Terminated, Estimated PCD: 2019-06-29